Cargando…

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK

OBJECTIVES: The aim of this study was to develop prediction models for the individual-level impacts of cardiovascular events on UK healthcare costs. METHODS: In the UK Biobank, people 40–70 years old, recruited in 2006–2010, were followed in linked primary (N = 192,983 individuals) and hospital care...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Junwen, Wu, Runguo, Williams, Claire, Emberson, Jonathan, Reith, Christina, Keech, Anthony, Robson, John, Wilkinson, Kenneth, Armitage, Jane, Gray, Alastair, Simes, John, Baigent, Colin, Mihaylova, Borislava
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085892/ https://www.ncbi.nlm.nih.gov/pubmed/36826687 http://dx.doi.org/10.1007/s40273-022-01219-6

Ejemplares similares

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2019)

Hospital costs associated with adverse events in people with diabetes in the UK
por: Keng, Mi Jun, et al.
Publicado: (2022)

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
por: Kent, Seamus, et al.
Publicado: (2015)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2017)

Impact of CKD on Household Income
por: Morton, Rachael L., et al.
Publicado: (2017)

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
por: Mihaylova, Borislava, et al.
Publicado: (2016)

Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK
por: Wu, Runguo, et al.
Publicado: (2021)

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD
por: Morton, Rachael L., et al.
Publicado: (2016)

Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort
por: Keng, Mi Jun, et al.
Publicado: (2022)

Decrements in health‐related quality of life associated with adverse events in people with diabetes
por: Keng, Mi Jun, et al.
Publicado: (2021)

Cost-Effectiveness of Pre-Referral Antimalarial, Antibacterial, and Combined Rectal Formulations for Severe Febrile Illness
por: Buchanan, James, et al.
Publicado: (2010)

Review of Statistical Methods for Analysing Healthcare Resources and Costs
por: Mihaylova, Borislava, et al.
Publicado: (2011)

The effect of diabetes complications on health-related quality of life: estimating the bias due to unobserved heterogeneity using the UKPDS
por: Alva, Maria L, et al.
Publicado: (2011)

Systematic review of randomised and observational evidence of effects of treatments of carotid stenosis to prevent stroke
por: Lokuge, Kusal, et al.
Publicado: (2015)

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017
por: Thalmann, Inna, et al.
Publicado: (2023)

Hospital costs in relation to body-mass index in 1·1 million women in England: a prospective cohort study
por: Kent, Seamus, et al.
Publicado: (2017)

Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis
por: Mafham, Marion, et al.
Publicado: (2011)

Body mass index and use and costs of primary care services among women aged 55–79 years in England: a cohort and linked data study
por: Kent, Seamus, et al.
Publicado: (2018)

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank
por: Zhu, Pengfei, et al.
Publicado: (2020)

Developing a lifetime disease model from RCT data using parametric models with time-updated covariates
por: Schlackow, Iryna, et al.
Publicado: (2013)

Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials
por: Staplin, Natalie, et al.
Publicado: (2021)

Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
por: Herrington, William, et al.
Publicado: (2015)

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection
por: Reith, C., et al.
Publicado: (2017)

Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)
por: Haynes, Richard, et al.
Publicado: (2014)

Impact of Outcome Adjudication in Kidney Disease Trials: Observations From the Study of Heart and Renal Protection
por: Herrington, William G., et al.
Publicado: (2023)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
por: Storey, Benjamin C., et al.
Publicado: (2018)

Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data
por: Schlackow, Iryna, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs Associated with Ketosis Events in Pediatric and Adult Patients with Type 1 Diabetes Mellitus in the UK
por: Thalange, Nandu, et al.
Publicado: (2017)

Overview of healthcare in the UK
por: Grosios, Konstantina, et al.
Publicado: (2010)

Out-of-Pocket Costs and Other Determinants of Access to Healthcare for Children with Febrile Illnesses: A Case-Control Study in Rural Tanzania
por: Castellani, Joëlle, et al.
Publicado: (2015)

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials
por: Scally, Benjamin, et al.
Publicado: (2018)

Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease
por: Herrington, William, et al.
Publicado: (2017)

Prenatal healthcare after sentencing reform: heterogeneous effects for prenatal healthcare access and equity
por: Jahn, Jaquelyn L., et al.
Publicado: (2022)

Exploring how ward staff engage with the implementation of a patient safety intervention: a UK-based qualitative process evaluation
por: Sheard, Laura, et al.
Publicado: (2017)

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
por: Staplin, Natalie, et al.
Publicado: (2016)

Advancing UK regulatory science and innovation in healthcare
por: Calvert, Melanie J, et al.
Publicado: (2020)

The Patient Feedback Response Framework – Understanding why UK hospital staff find it difficult to make improvements based on patient feedback: A qualitative study
por: Sheard, Laura, et al.
Publicado: (2017)

The impact of carceral churn and healthcare organizations on HIV/AIDS incidence in Arkansas()
por: Haimson, Chloe E., et al.
Publicado: (2023)

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection
por: Mafham, Marion M, et al.
Publicado: (2018)

Effectiveness of group arts therapies (art therapy, dance movement therapy and music therapy) compared to group counselling for diagnostically heterogeneous psychiatric community patients: study protocol for a randomised controlled trial in mental health services (the ERA study)
por: Carr, Catherine E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cit5k39drkrsai8k30ul2v3f2e